203 related articles for article (PubMed ID: 8743334)
1. Clinical pharmacokinetics of therapeutic bile acids.
Crosignani A; Setchell KD; Invernizzi P; Larghi A; Rodrigues CM; Podda M
Clin Pharmacokinet; 1996 May; 30(5):333-58. PubMed ID: 8743334
[TBL] [Abstract][Full Text] [Related]
2. Inappropriate ileal conservation of bile acids in cholestatic liver disease: homeostasis gone awry.
Hofmann AF
Gut; 2003 Sep; 52(9):1239-41. PubMed ID: 12912852
[No Abstract] [Full Text] [Related]
3. Ursodeoxycholic acid improves the hepatic metabolism of essential fatty acids and retinol in children with cystic fibrosis.
Lepage G; Paradis K; Lacaille F; Sénéchal L; Ronco N; Champagne J; Lenaerts C; Roy CC; Rasquin-Weber A
J Pediatr; 1997 Jan; 130(1):52-8. PubMed ID: 9003851
[TBL] [Abstract][Full Text] [Related]
4. High-fat diets enhance and delay ursodeoxycholic acid absorption but elevate circulating hydrophobic bile salts.
Huang L; Wei W; Huang X; Li X; Liu H; Gui L; Jiang J; Wan L; Zhou X; Ding J; Jiang X; Zhang B; Lan K
Front Pharmacol; 2023; 14():1168144. PubMed ID: 37138846
[No Abstract] [Full Text] [Related]
5. Cholestasis impairs gut microbiota development and bile salt hydrolase activity in preterm neonates.
Lynch LE; Hair AB; Soni KG; Yang H; Gollins LA; Narvaez-Rivas M; Setchell KDR; Preidis GA
Gut Microbes; 2023; 15(1):2183690. PubMed ID: 36843227
[TBL] [Abstract][Full Text] [Related]
6. Management of biliary stones in bariatric surgery.
Tustumi F; Pinheiro Filho JEL; Stolzemburg LCP; Serigiolle LC; Costa TN; Pajecki D; Santo MA; Nahas SC
Ther Adv Gastrointest Endosc; 2022; 15():26317745221105087. PubMed ID: 36388729
[TBL] [Abstract][Full Text] [Related]
7. Elevated Levels of Toxic Bile Acids in Serum of Cystic Fibrosis Patients with
Tabori H; Schneider J; Lüth S; Zagoya C; Barucha A; Lehmann T; Kauf E; Barth A; Mainz JG
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293293
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Zhuyu Pill Intervention in a Cholestasis Rat Model: Mutual Effects on Fecal Metabolism and Microbial Diversity.
Yu H; Liu C; Zhang F; Wang J; Han J; Zhou X; Wen Y; Shen T
Front Pharmacol; 2021; 12():695035. PubMed ID: 34539394
[TBL] [Abstract][Full Text] [Related]
9. Ursodeoxycholic acid enriches intestinal bile salt hydrolase-expressing Bacteroidetes in cholestatic pregnancy.
Ovadia C; Perdones-Montero A; Fan HM; Mullish BH; McDonald JAK; Papacleovoulou G; Wahlström A; Ståhlman M; Tsakmaki A; Clarke LCD; Sklavounos A; Dixon PH; Bewick GA; Walters JRF; Marschall HU; Marchesi JR; Williamson C
Sci Rep; 2020 Mar; 10(1):3895. PubMed ID: 32127609
[TBL] [Abstract][Full Text] [Related]
10. Diversification of host bile acids by members of the gut microbiota.
Winston JA; Theriot CM
Gut Microbes; 2020; 11(2):158-171. PubMed ID: 31595814
[TBL] [Abstract][Full Text] [Related]
11. Tauroursodeoxycholic Acid Improves Motor Symptoms in a Mouse Model of Parkinson's Disease.
Rosa AI; Duarte-Silva S; Silva-Fernandes A; Nunes MJ; Carvalho AN; Rodrigues E; Gama MJ; Rodrigues CMP; Maciel P; Castro-Caldas M
Mol Neurobiol; 2018 Dec; 55(12):9139-9155. PubMed ID: 29651747
[TBL] [Abstract][Full Text] [Related]
12. Structure of NADP
Wang R; Wu J; Jin DK; Chen Y; Lv Z; Chen Q; Miao Q; Huo X; Wang F
Acta Crystallogr F Struct Biol Commun; 2017 May; 73(Pt 5):246-252. PubMed ID: 28471355
[TBL] [Abstract][Full Text] [Related]
13. Discovery of tauroursodeoxycholic acid biotransformation enzymes from the gut microbiome of black bears using metagenomics.
Song C; Wang B; Tan J; Zhu L; Lou D
Sci Rep; 2017 Apr; 7():45495. PubMed ID: 28436439
[TBL] [Abstract][Full Text] [Related]
14. Management Of Primary Sclerosing Cholangitis.
Sandhu BS; Luketic VA
Gastroenterol Hepatol (N Y); 2006 Nov; 2(11):843-849. PubMed ID: 28381955
[TBL] [Abstract][Full Text] [Related]
15. Tauroursodeoxycholic bile acid arrests axonal degeneration by inhibiting the unfolded protein response in X-linked adrenoleukodystrophy.
Launay N; Ruiz M; Grau L; Ortega FJ; Ilieva EV; Martínez JJ; Galea E; Ferrer I; Knecht E; Pujol A; Fourcade S
Acta Neuropathol; 2017 Feb; 133(2):283-301. PubMed ID: 28004277
[TBL] [Abstract][Full Text] [Related]
16. A Systems Model for Ursodeoxycholic Acid Metabolism in Healthy and Patients With Primary Biliary Cirrhosis.
Zuo P; Dobbins RL; O'Connor-Semmes RL; Young MA
CPT Pharmacometrics Syst Pharmacol; 2016 Aug; 5(8):418-26. PubMed ID: 27537780
[TBL] [Abstract][Full Text] [Related]
17. Bile Acids Reduce Prion Conversion, Reduce Neuronal Loss, and Prolong Male Survival in Models of Prion Disease.
Cortez LM; Campeau J; Norman G; Kalayil M; Van der Merwe J; McKenzie D; Sim VL
J Virol; 2015 Aug; 89(15):7660-72. PubMed ID: 25972546
[TBL] [Abstract][Full Text] [Related]
18. Estimation of biliary excretion of foreign compounds using properties of molecular structure.
Sharifi M; Ghafourian T
AAPS J; 2014 Jan; 16(1):65-78. PubMed ID: 24202722
[TBL] [Abstract][Full Text] [Related]
19. TUDCA, a bile acid, attenuates amyloid precursor protein processing and amyloid-β deposition in APP/PS1 mice.
Nunes AF; Amaral JD; Lo AC; Fonseca MB; Viana RJ; Callaerts-Vegh Z; D'Hooge R; Rodrigues CM
Mol Neurobiol; 2012 Jun; 45(3):440-54. PubMed ID: 22438081
[TBL] [Abstract][Full Text] [Related]
20. No significant effect of the SLCO1B1 polymorphism on the pharmacokinetics of ursodeoxycholic acid.
Xiang X; Vakkilainen J; Backman JT; Neuvonen PJ; Niemi M
Eur J Clin Pharmacol; 2011 Nov; 67(11):1159-67. PubMed ID: 21655991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
